Molecular structure of staphylococcus and streptococcus superantigens. 1995

P M Schlievert, and G A Bohach, and D H Ohlendorf, and C V Stauffacher, and D Y Leung, and D L Murray, and G S Prasad, and C A Earhart, and L M Jablonski, and M L Hoffmann, and Y I Chi
Department of Microbiology, University of Minnesota Medical School, Minneapolis, 55455-0312, USA.

Staphylococcus aureus and streptococci, notably those belonging to group A, make up a large family of true exotoxins referred to as pyrogenic toxin superantigens. These toxins cause toxic shock-like syndromes and have been implicated in several allergic and autoimmune diseases. Included within this group of proteins are the staphylococcal enterotoxins, designated serotypes A, B, Cn, D, E, and G; two forms of toxic shock syndrome toxin-1 also made by Staphylococcus aureus; the group A streptococcal pyrogenic exotoxins, serotypes A, B, and C; and recently described toxins associated with groups B, C, F, and G streptococci. The nucleotide sequences of the genes for all of the toxins except those from the groups B, C, F, and G streptococcal strains have been sequenced. The sequencing studies indicate that staphylococcal enterotoxins B and C and streptococcal pyrogenic exotoxin A share highly significant sequence similarity; staphylococcal enterotoxins A, D, and E share highly significant sequence similarity; and toxic shock syndrome toxin-1 and streptococcal pyrogenic exotoxin B and C share little, if any, sequence similarity with any of the toxins. Despite the dissimilarities seen in primary amino acid sequence among some members of the toxin family, it was hypothesized that there was likely to be significant three-dimensional structure similarity among all the toxins. The three-dimensional structures of three of the pyrogenic toxin superantigens have been determined recently. The structural features of two of these, toxic shock syndrome toxin-1 and enterotoxin C3, are presented. Toxic shock syndrome-1 exists as a protein with two major domains, referred to as A and B. The molecule begins with a short N-terminal alpha-helix that then leads into a clawshaped structure in domain B that is made up of beta strands.

UI MeSH Term Description Entries
D008958 Models, Molecular Models used experimentally or theoretically to study molecular shape, electronic properties, or interactions; includes analogous molecules, computer-generated graphics, and mechanical structures. Molecular Models,Model, Molecular,Molecular Model
D011487 Protein Conformation The characteristic 3-dimensional shape of a protein, including the secondary, supersecondary (motifs), tertiary (domains) and quaternary structure of the peptide chain. PROTEIN STRUCTURE, QUATERNARY describes the conformation assumed by multimeric proteins (aggregates of more than one polypeptide chain). Conformation, Protein,Conformations, Protein,Protein Conformations
D004768 Enterotoxins Substances that are toxic to the intestinal tract causing vomiting, diarrhea, etc.; most common enterotoxins are produced by bacteria. Staphylococcal Enterotoxin,Enterotoxin,Staphylococcal Enterotoxins,Enterotoxin, Staphylococcal,Enterotoxins, Staphylococcal
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D001427 Bacterial Toxins Toxic substances formed in or elaborated by bacteria; they are usually proteins with high molecular weight and antigenicity; some are used as antibiotics and some to skin test for the presence of or susceptibility to certain diseases. Bacterial Toxin,Toxins, Bacterial,Toxin, Bacterial
D012772 Shock, Septic Sepsis associated with HYPOTENSION or hypoperfusion despite adequate fluid resuscitation. Perfusion abnormalities may include but are not limited to LACTIC ACIDOSIS; OLIGURIA; or acute alteration in mental status. Endotoxin Shock,Septic Shock,Shock, Endotoxic,Shock, Toxic,Toxic Shock,Toxic Shock Syndrome,Endotoxin Shocks,Shock Syndrome, Toxic,Shock, Endotoxin,Shocks, Endotoxin,Toxic Shock Syndromes
D013203 Staphylococcal Infections Infections with bacteria of the genus STAPHYLOCOCCUS. Infections, Staphylococcal,Staphylococcus aureus Infection,Staphylococcal Infection,Staphylococcus aureus Infections
D013210 Staphylococcus A genus of gram-positive, facultatively anaerobic, coccoid bacteria. Its organisms occur singly, in pairs, and in tetrads and characteristically divide in more than one plane to form irregular clusters. Natural populations of Staphylococcus are found on the skin and mucous membranes of warm-blooded animals. Some species are opportunistic pathogens of humans and animals.
D013290 Streptococcal Infections Infections with bacteria of the genus STREPTOCOCCUS. Group A Strep Infection,Group A Streptococcal Infection,Group A Streptococcal Infections,Group B Strep Infection,Group B Streptococcal Infection,Group B Streptococcal Infections,Infections, Streptococcal,Infection, Streptococcal,Streptococcal Infection
D013291 Streptococcus A genus of gram-positive, coccoid bacteria whose organisms occur in pairs or chains. No endospores are produced. Many species exist as commensals or parasites on man or animals with some being highly pathogenic. A few species are saprophytes and occur in the natural environment.

Related Publications

P M Schlievert, and G A Bohach, and D H Ohlendorf, and C V Stauffacher, and D Y Leung, and D L Murray, and G S Prasad, and C A Earhart, and L M Jablonski, and M L Hoffmann, and Y I Chi
June 2007, Current opinion in infectious diseases,
P M Schlievert, and G A Bohach, and D H Ohlendorf, and C V Stauffacher, and D Y Leung, and D L Murray, and G S Prasad, and C A Earhart, and L M Jablonski, and M L Hoffmann, and Y I Chi
January 2002, Zhurnal mikrobiologii, epidemiologii i immunobiologii,
P M Schlievert, and G A Bohach, and D H Ohlendorf, and C V Stauffacher, and D Y Leung, and D L Murray, and G S Prasad, and C A Earhart, and L M Jablonski, and M L Hoffmann, and Y I Chi
January 2020, Infectious disorders drug targets,
P M Schlievert, and G A Bohach, and D H Ohlendorf, and C V Stauffacher, and D Y Leung, and D L Murray, and G S Prasad, and C A Earhart, and L M Jablonski, and M L Hoffmann, and Y I Chi
January 2000, FEMS immunology and medical microbiology,
P M Schlievert, and G A Bohach, and D H Ohlendorf, and C V Stauffacher, and D Y Leung, and D L Murray, and G S Prasad, and C A Earhart, and L M Jablonski, and M L Hoffmann, and Y I Chi
March 2006, Clinical and experimental immunology,
P M Schlievert, and G A Bohach, and D H Ohlendorf, and C V Stauffacher, and D Y Leung, and D L Murray, and G S Prasad, and C A Earhart, and L M Jablonski, and M L Hoffmann, and Y I Chi
January 1991, Current topics in microbiology and immunology,
P M Schlievert, and G A Bohach, and D H Ohlendorf, and C V Stauffacher, and D Y Leung, and D L Murray, and G S Prasad, and C A Earhart, and L M Jablonski, and M L Hoffmann, and Y I Chi
May 2002, Current allergy and asthma reports,
P M Schlievert, and G A Bohach, and D H Ohlendorf, and C V Stauffacher, and D Y Leung, and D L Murray, and G S Prasad, and C A Earhart, and L M Jablonski, and M L Hoffmann, and Y I Chi
January 2003, Methods in molecular biology (Clifton, N.J.),
P M Schlievert, and G A Bohach, and D H Ohlendorf, and C V Stauffacher, and D Y Leung, and D L Murray, and G S Prasad, and C A Earhart, and L M Jablonski, and M L Hoffmann, and Y I Chi
December 2014, Journal of microbiological methods,
P M Schlievert, and G A Bohach, and D H Ohlendorf, and C V Stauffacher, and D Y Leung, and D L Murray, and G S Prasad, and C A Earhart, and L M Jablonski, and M L Hoffmann, and Y I Chi
January 1999, The Journal of experimental medicine,
Copied contents to your clipboard!